3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
9
Breast
9
Gynecologic
4
Plasma cell
2
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
CNS
2
Other neoplasm
1
Myeloid
1
Gastrointestinal
1
Dermatologic
1
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Disease
1
Anxiety Disorders
1
Agnosia
1
Interventions
Docetaxel
390
pembrolizumab
325
Prednisone
284
Gemcitabine
273
enzalutamide
254
Radiotherapy
251
Nivolumab
247
Magnetic Resonance Spectroscopy
247
Cisplatin
209
Abiraterone Acetate
197
Radiosurgery
184
Leuprolide
182
Sunitinib
169
Carboplatin
161
bicalutamide
148
Goserelin
145
Androgen Antagonists
142
Specimen Handling
138
Ipilimumab
128
Paclitaxel
125
Cyclophosphamide
116
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
110
Bevacizumab
109
Everolimus
107
apalutamide
98
cabozantinib
97
abiraterone
97
Sorafenib
97
atezolizumab
96
Radiation
89
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Music Therapy
×
Genitourinary
×
Clear all
NCT07464964
2026-03-11
MUSIC-PRT
Dokuz Eylul University
Phase NA
Completed
60 enrolled
NCT07204301
2025-10-02
Flexi-comfort
Western University, Canada
Phase NA
Not yet recruiting
378 enrolled